Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- AML (1)
- Acute/subacute exposure (1)
- Anatomy and Neurobiology (1)
- Catalase (1)
- Collagen T1A2 (1)
-
- Connective tissue growth factor (CTGF) (1)
- Fetal vulnerability during pregnancy (1)
- Flavopiridol (1)
- Growth factors (1)
- MLL (1)
- Maternal pre-eclampsia (1)
- Ozone pollution (1)
- Placenta (1)
- Reactive oxygen species (1)
- Superoxide dismutase 1 (SOD1) (1)
- Vascular endothelial cadherin (VE-Cadherin) (1)
- Vascular endothelial cell adhesion molecule 1 (VCAM-1) (1)
- Venetoclax (1)
- Zebrafish (1)
- Publication Type
Articles 1 - 2 of 2
Full-Text Articles in Biochemistry
Gestational Vulnerability To Ozone Air Pollution - A Placental Story, Vishnupriya Alavala, Sarah Brent, Russell Hunter, Matthew J. Campen, Andrew Ottens
Gestational Vulnerability To Ozone Air Pollution - A Placental Story, Vishnupriya Alavala, Sarah Brent, Russell Hunter, Matthew J. Campen, Andrew Ottens
Undergraduate Research Posters
About 99% of the global population resides in areas with air pollution surpassing World Health Organization standards. Air pollution is associated with adverse neonatal health outcomes such as low fetal birth weight and an increased risk for maternal pre-eclampsia. A particularly reactive air pollutant is ozone, which forms reactive oxygen species that induce cellular damage. Research exists on the dispersion of reactive oxygen species through the bloodstream leading to fetal vulnerability during pregnancy, specifically via the placenta. Yet, placental and fetal development is a temporal process with varied susceptibility to negative gestational outcomes.
To addressing this gap, our laboratory utilized …
Zebrafish Model Of Mll-Rearranged Acute Myeloid Leukemia, Alex J. Belt
Zebrafish Model Of Mll-Rearranged Acute Myeloid Leukemia, Alex J. Belt
Theses and Dissertations
Acute myeloid leukemia (AML) is the second most common type of leukemia and accounts for 80% of adult acute leukemia cases and is characterized by the accumulation of poorly or undifferentiated myeloid blast cells. Standard treatment includes chemotherapy, which if unsuccessful, is followed by more rigorous chemotherapy as well as stem cell transplantation. Considering most patients are over the age of 45, these more rigorous therapies are not always possible, and as such, new therapies must be developed. Furthermore, AML patients harboring a chromosomal rearrangement involving Multiple Lineage Leukemia (MLL) that results in the expression of an MLL fusion protein …